Alzheimer’s disease is a neurodegenerative disease caused by the buildup in the brain of extracellular plaques (made of a proteinaceous material called amyloid) and intracellular tangles (made up of tau protein).
There is mounting evidence that cannabinoids have the potential to work as neuroprotective agents (i.e. those that protect destruction of neurons) through processes such as neutralizing free radicals which cause damage, reducing inflammation, improving function of mitochondria, and clearing away cellular debris.
Studies indicate high CBD’s could help ward off neuronal cell death in the face of neurodegeneration and provide evidence that plant-based cannabinoids may be effective in reversing the accumulation of amyloid in the brain by assisting in its transport across the blood-brain barrier and out of the brain. Additional research suggest that strains with low THC and high CBD content are well suited to fight alzheimer’s symptoms.